Search the Newsreel

MYR Group (MYRG) Q2 Earnings and Revenues Beat Estimates

MYR Group (MYRG) came out with quarterly earnings of $3.17 per share, beating the Zacks Consensus Estimate of $2.53 per share. This compares to earnings of $1.7 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

MYR GROUP ($MYRG) Releases Q2 2026 Earnings, Stock Rises

Lazard Asset Management LLC Grows Stock Holdings in MYR Group, Inc. $MYRG

Lazard Asset Management LLC significantly increased its stake in MYR Group, Inc. (NASDAQ:MYRG) by 699.1% during the first quarter, now owning 74,950 shares valued at $21.16 million. Other hedge funds also adjusted their positions, and insider trades show directors selling shares, though insiders still …

Dimensional Fund Advisors LP Boosts Stock Holdings in MYR Group, Inc. $MYRG

Dimensional Fund Advisors LP increased its stake in MYR Group, Inc. (NASDAQ:MYRG) by 2.8% during the first quarter, now owning 376,175 shares valued at $106.19 million. Other institutional investors have also adjusted their positions, with hedge funds and institutional investors collectively owning 88.90% of …

Emyria Delivers $4.3 Million Full-Year Revenue as Victorian Clinic Opens and Depression Treatment Data Improves

MYR Group’s (NASDAQ:MYRG) Q2 CY2026: Strong Sales

MYR Group's (NASDAQ:MYRG) Q2 CY2026: Strong Sales Electrical construction and infrastructure services provider MYR Group (NASDAQ:MYRG) reported Q2 CY2026 results exceeding the market's revenue expectations , with sales up 20.1% year on year to $1.08 billion. Its GAAP profit of $3.17 per share was …

Myriad Genetics (MYGN) Reports Q2: Everything You Need To Know Ahead Of Earnings

Myriad Genetics (MYGN) is set to report Q2 earnings this Thursday, with analysts expecting a 2.5% year-on-year revenue decline. The company missed revenue expectations last quarter, and its stock is down 9.5% over the last month, contrasting with a 4.4% average rise in the …

Myriad Genetics Inc (MYGN) Financial Health: Profitability & Balance Sheet Analysis

Myriad Genetics Inc (MYGN) has a stable financial status and high operating efficiency, ranking 93rd out of 199 companies in the Healthcare Equipment & Supplies industry with a score of 7.30. The company reported a Q4 revenue of $200.40 million, marking a 2.30% year-over-year …

Are Investors Undervaluing MYR Group Inc. (NASDAQ:MYRG) By 44%?

This article analyzes whether MYR Group Inc. (NASDAQ:MYRG) is undervalued by 44% based on a 2-stage Discounted Cash Flow (DCF) model. The analysis suggests a fair value of US$252, significantly higher than the current share price of US$141. Key assumptions for the valuation, including …

Castleark Management LLC Buys Shares of 17,560 MYR Group, Inc. $MYRG

Castleark Management LLC acquired a new position in MYR Group, Inc. (NASDAQ:MYRG) during the first quarter, purchasing 17,560 shares valued at approximately $4.96 million, making them owners of 0.11% of the company. Other institutional investors also adjusted their holdings in MYRG, while the company …

What To Expect From MYR Group’s (MYRG) Q2 Earnings

MYR Group (MYRG), an electrical construction and infrastructure services provider, is set to report its Q2 earnings this Wednesday afternoon. Analysts expect the company's revenue to grow by 10.9% year-on-year, an improvement from the previous year, although MYR Group has missed revenue estimates multiple …

Myriad Genetics rebuilt its AI platform after costs ballooned. Now, it can process documents in seconds.

Myriad Genetics significantly reduced document processing time from 10 minutes to 20 seconds per document after rebuilding its AI platform with Amazon Web Services. Initially, an internally developed AI tool, "Image Genius," proved too costly and inefficient. By leveraging AWS's Generative AI Innovation Center …

MYRG|MYR Group Inc|Price:360.466|Chg%:-18.704

This article provides a detailed financial overview for MYR Group Inc (MYRG), including its latest earnings report, key financial indicators, and historical performance data. It features quarterly and annual breakdowns of EPS, Revenue, Net Profit, Net Margin, Gross Margin, and Debt to Assets ratio, …

Myriad Genetics Inc (MYGN) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Myriad Genetics Inc (MYGN), listing its major institutional holders such as BlackRock and Millennium Management. It also breaks down shareholder types, showing the dominance of investment advisors and hedge funds. Additionally, the report includes institutional shareholding trends …

Myriad Genetics Inc (MYGN) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Myriad Genetics Inc's (MYGN) dividend and stock split history. It notes that the company has distributed $0.00 in dividends over the past five years and contains no specific dividend or stock split data. The page also includes current …

MYR Group, Inc. (NASDAQ:MYRG) Receives Consensus Rating of "Moderate Buy" from Analysts

MYR Group, Inc. (NASDAQ:MYRG) has received a consensus "Moderate Buy" rating from analysts, with an average 1-year price target of $389.83. Recent analyst reports show a mix of ratings, including a downgrade from "strong-buy" to "hold" by Zacks and an increased target price by …

MYR Group Inc (MYRG) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of MYR Group Inc (MYRG), outlining its major institutional holders and the types of shareholders. It provides a breakdown of proportional holdings by entities like BlackRock and Wellington Management, as well as an overview of institutional shareholding trends …

MYGN|Myriad Genetics Inc|Price:5.610|Chg%:-0.090

This article provides a detailed financial overview of Myriad Genetics Inc. (MYGN), including its latest stock price, market cap, and a comprehensive breakdown of its income statement, balance sheet, and cash flow statement. It highlights the company's recent earnings report, showing revenue and EPS …

Hsbc Holdings PLC Buys 2,856 Shares of MYR Group, Inc. $MYRG

Hsbc Holdings PLC increased its stake in MYR Group, Inc. (NASDAQ:MYRG) by 45.5% in the first quarter, purchasing an additional 2,856 shares to own a total of 9,137 shares valued at $2,542,000. Other institutional investors also adjusted their positions in MYR Group, with several …

First Trust Advisors LP Increases Holdings in MYR Group, Inc. $MYRG

First Trust Advisors LP significantly increased its stake in MYR Group, Inc. by 23.5% in the first quarter, holding over 203,000 shares valued at $57.5 million. This coincides with MYR Group reporting strong quarterly results, exceeding EPS and revenue estimates with 20% year-over-year revenue …

Myriad Genetics Inc (MYGN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Myriad Genetics Inc (MYGN) by business segment and by region. For FY2025, the company's revenue heavily relies on Hereditary Cancer (45.17%) and Prenatal (22.60%) segments, with most revenue generated in the United States (93.15%). The data summarizes …

MYRG|MYR Group Inc|Price:379.170|Chg%:-28.230

MYR Group Inc. (MYRG) saw its stock price decline by 6.93% to $379.170, a decrease of $28.230. The company is a holding company providing specialty electrical construction services through its Transmission and Distribution (T&D) and Commercial and Industrial (C&I) segments. Key executives and prominent …

Allspring Global Investments Holdings LLC Has $3.27 Million Stock Position in MYR Group, Inc. $MYRG

Allspring Global Investments Holdings LLC reduced its stake in MYR Group, Inc. (NASDAQ:MYRG) by 49.7% in the first quarter, now holding 11,314 shares valued at $3.27 million. Other institutional investors also adjusted their positions, with the company's stock currently trading at $379.17 and analysts …

Myriad Genetics (MYGN) Expected to Announce Quarterly Earnings on Thursday

MYR Group Inc (MYRG) Shares Fall 6.9% -- GF Value Says Still Overvalued

MYR Group Inc (MYRG) shares fell by 6.9% on July 24, 2026, bringing the current price to $379.17. Despite strong fundamentals and a high GF Score of 83/100, GuruFocus calculates MYRG's intrinsic value (GF Value) at $183.35, indicating the stock is significantly overvalued by …

Militia Capital Management LLC Invests $847,000 in MYR Group, Inc. $MYRG

Militia Capital Management LLC has initiated a new position in MYR Group, Inc. (NASDAQ:MYRG) during the first quarter, purchasing 3,000 shares valued at approximately $847,000. This investment comes as MYR Group reported strong quarterly results, exceeding both EPS and revenue estimates, with a 20% …

Myriad Genetics to Release Second Quarter 2026 Financial Results on July 30, 2026

Myriad Genetics, Inc. SALT LAKE CITY, July 23, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its second quarter 2026 earnings conference call at 4:30 pm ET on Thursday, July 30, 2026. …

Earnings Preview: MYR Group to Report Financial Results Post-market on July 29

This article announces that MYR Group (NASDAQ: MYRG) is scheduled to report its financial results post-market on July 29, 2026. The report includes details on the company's past earnings per share (EPS) performance, revenue trends, and analyst expectations for the upcoming quarter. Investors will …

3 Reasons MYGN is Risky and 1 Stock to Buy Instead

3 Reasons MYGN is Risky and 1 Stock to Buy Instead Myriad Genetics has been treading water for the past six months, recording a small loss of 3.6% while holding steady at $5.66. The stock also fell short of the S&P 500's 8.6% gain …

Myriad Genetics stock trades sideways as investors digest recent revenue growth and precision oncolo

Myriad Genetics (NASDAQ: MYGN) stock is influenced by its revenue growth in precision oncology and plans to improve profitability. The company has shown a low double-digit percentage increase in annual revenue, reaching approximately $700 million, driven by oncology and women’s health testing. While still …

MYR Group stock trades near recent high as strong backlog supports outlook

MYR Group Inc. (MYRG) stock is trading near a recent high, supported by double-digit revenue growth in 2024, a robust project backlog, and a conservative leverage profile. The electrical construction services company saw annual revenues reach $3.51 billion, a 16% increase, primarily driven by …

Myriad Genetics to Webcast Q2 Business Update July 30

Myriad Genetics (NASDAQ: MYGN) will release its second-quarter 2026 financial results after market close on Thursday, July 30, 2026. This will be followed by an earnings conference call at 4:30 p.m. ET, during which management will provide a financial overview and business update. A …

Myriad Genetics to Hold Second Quarter 2026 Earnings Conference Call on July 30

MYR Group (MYRG) to Announce Earnings on Wednesday

MYR Group (NASDAQ: MYRG) is scheduled to release its Q2 2026 earnings on Wednesday, July 29th, with analysts anticipating $2.61 EPS and $995.7 million in revenue. This follows a strong performance in the prior quarter where the company surpassed expectations with $2.99 EPS and …

Meeder Asset Management Inc. Sells 5,608 Shares of MYR Group, Inc. $MYRG

Meeder Asset Management Inc. significantly reduced its stake in MYR Group, Inc. (NASDAQ:MYRG) by 82.7% in the first quarter, selling 5,608 shares and leaving them with 1,172 shares worth $331,000. This report also highlights other institutional investment changes, recent insider selling activity by two …

Myriad Genetics Launches FirstGene® Multiple Prenatal Screen

Myriad Genetics, Inc. has announced the full commercial launch of its FirstGene® Multiple Prenatal Screen. This new diagnostic test is unique in its ability to simultaneously run four prenatal genetic screens from a single blood draw as early as eight weeks gestation. The FirstGene …